Back to VP VANGUARD PORTFOLIO MANAGEMENT LLC
PTGX2 quarters
Position history for VPVANGUARD PORTFOLIO MANAGEMENT LLC's holdings in PROTAGONIST THERAPEUTICS INC
Yes. Vanguard Portfolio Management holds 3,629,298 shares of PTGX (Protagonist Therapeutics), worth $444.9M, as of its Q2 2026 13F filing. It increased the position by 148,087 shares (+4.3%) from Q1 2026. Vanguard Portfolio Management has held PTGX in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$444.9M
Current Shares
3.6M
Total Value Change
+$78M
Total Shares Change
+148,087
Quarter-by-Quarter History
Other major holders of PTGX: BlackRock, Inc., FARALLON CAPITAL MANAGEMENT, L.L.C.